Questions about authorisation of alteplase for ischaemic stroke

Lancet. 2014 Aug 23;384(9944):659-60. doi: 10.1016/S0140-6736(14)61385-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Brain Ischemia / drug therapy*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator